OLMA Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 19.40%

Insider Buying (Last 12 Months): $1,728,000.00

Insider Selling (Last 12 Months): $42,151,106.87

Olema Pharmaceuticals Insider Trading History Chart

Olema Pharmaceuticals Share Price & Price History

^$4.41

▲ +0.04 (0.92%)

As of 03/14/2025 05:00 PM ET

Days: 30 | 90 | 365

Olema Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/8/2025	Bain Capital Life Sciences Inv	Major Shareholder	Buy	300,000	$5.76	$1,728,000.00	7,800,000
12/17/2024	G. Walmsley Graham	Director	Sell	700,761	$6.75	$4,730,136.75
12/10/2024	Cyrus Harmon	Director	Sell	8,256	$9.37	$77,358.72	772,277
12/10/2024	David C Myles	Insider	Sell	12,452	$9.38	$116,799.76	611,947
12/10/2024	Sean Bohen	CEO	Sell	52,328	$9.37	$490,313.36	298,836
8/1/2024	Biocapital Advisors L Paradigm	Major Shareholder	Sell	2,400,000	$14.91	$35,784,000.00	783,118
7/29/2024	Cyrus Harmon	Director	Sell	4,066	$15.58	$63,348.28	752,217
7/11/2024	Cyrus Harmon	Director	Sell	5,000	$12.26	$61,300.00	756,283
6/28/2024	Cyrus Harmon	Director	Sell	20,000	$10.77	$215,400.00	761,283
6/3/2024	Cyrus Harmon	Director	Sell	5,000	$10.93	$54,650.00	786,283
5/31/2024	Cyrus Harmon	Director	Sell	15,000	$9.41	$141,150.00	791,283
5/6/2024	Cyrus Harmon	Director	Sell	5,000	$10.92	$54,600.00	806,283
4/30/2024	Cyrus Harmon	Director	Sell	15,000	$9.51	$142,650.00	811,283
3/28/2024	Cyrus Harmon	Director	Sell	20,000	$10.97	$219,400.00	826,283
2/29/2024	Cyrus Harmon	Director	Sell	25,000	$12.41	$310,250.00	846,283
1/31/2024	Cyrus Harmon	Director	Sell	25,000	$12.23	$305,750.00	876,283
12/6/2023	Biocapital Advisors L Paradigm	Major Shareholder	Buy	100,000	$11.60	$1,160,000.00	6,590,981
12/5/2023	G. Walmsley Graham	Director	Buy	131,870	$14.19	$1,871,235.30	1,800,000
11/30/2023	Cyrus Harmon	Director	Sell	25,000	$12.57	$314,250.00	926,283
11/21/2023	Cyrus Harmon	Director	Sell	4,192	$14.86	$62,293.12	955,272
11/21/2023	Naseem Zojwalla	Insider	Sell	7,461	$14.84	$110,721.24	37,759
11/21/2023	Sean Bohen	CEO	Sell	29,293	$14.88	$435,879.84	172,857
11/8/2023	David C Myles	Insider	Sell	200	$17.61	$3,522.00	561,270
11/3/2023	David C Myles	Insider	Sell	541	$17.51	$9,472.91	561,470
11/2/2023	Cyrus Harmon	Director	Sell	5,000	$15.64	$78,200.00	943,714
11/1/2023	David C Myles	Insider	Sell	6,668	$15.02	$100,153.36	565,343
10/31/2023	Cyrus Harmon	Director	Sell	25,000	$12.05	$301,250.00	948,714
9/29/2023	Cyrus Harmon	Director	Sell	25,000	$12.41	$310,250.00	973,714
9/19/2023	David C Myles	Insider	Sell	20,000	$12.67	$253,400.00	572,011
9/12/2023	Bvf Partners L P/Il	Director	Buy	1,505,932	$9.84	$14,818,370.88	4,688,954
9/5/2023	Cyrus Harmon	Director	Sell	10,000	$11.62	$116,200.00	998,714
8/31/2023	Cyrus Harmon	Director	Sell	15,000	$9.36	$140,400.00	1,008,714
6/8/2023	Cyrus Harmon	Director	Sell	10,000	$6.30	$63,000.00	1,038,714
6/5/2023	Cyrus Harmon	Director	Sell	5,000	$6.04	$30,200.00	1,053,714
6/10/2022	Bvf Partners L P/Il	Director	Buy	200,000	$4.03	$806,000.00	3,913,676

See Full Table

SEC Filings (Institutional Ownership Changes) for Olema Pharmaceuticals (NASDAQ:OLMA)

91.78% of Olema Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Olema Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/25/2025	Polar Asset Management Partners Inc.	20,400	$0.12M	0.0%	N/A	0.036%
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	93,979	$0.55M	0.0%	+23.7%	0.164%
2/17/2025	Woodline Partners LP	1,357,479	$7.91M	0.1%	+0.2%	2.369%
2/17/2025	Squarepoint Ops LLC	48,829	$0.29M	0.0%	+205.8%	0.085%
2/17/2025	Two Sigma Investments LP	72,877	$0.43M	0.0%	-27.2%	0.127%
2/17/2025	Two Sigma Advisers LP	89,000	$0.52M	0.0%	-12.1%	0.155%
2/17/2025	Rafferty Asset Management LLC	81,424	$0.48M	0.0%	-10.0%	0.142%
2/17/2025	Point72 Asset Management L.P.	3,670,826	$21.40M	0.0%	-0.4%	6.406%
2/17/2025	Polar Asset Management Partners Inc.	20,400	$0.12M	0.0%	N/A	0.036%
2/17/2025	ProShare Advisors LLC	14,226	$83K	0.0%	+30.2%	0.025%
2/17/2025	MPM Bioimpact LLC	2,912,550	$16.98M	2.4%	+8.7%	5.083%
2/17/2025	Paradigm Biocapital Advisors LP	7,304,970	$42.59M	1.5%	+32.7%	12.749%
2/17/2025	Millennium Management LLC	979,219	$5.71M	0.0%	+1,154.4%	1.709%
2/17/2025	Lightspeed Management Company L.L.C.	1,930,894	$11.26M	3.1%	N/A	3.370%
2/17/2025	J. Goldman & Co LP	13,500	$79K	0.0%	-60.0%	0.024%
2/17/2025	Deutsche Bank AG	39,331	$0.23M	0.0%	+45.0%	0.069%
2/17/2025	D. E. Shaw & Co. Inc.	12,445	$73K	0.0%	-51.4%	0.022%
2/17/2025	Driehaus Capital Management LLC	220,264	$1.28M	0.0%	N/A	0.384%
2/17/2025	Deep Track Capital LP	3,442,833	$20.07M	0.7%	-13.9%	6.008%
2/17/2025	Cubist Systematic Strategies LLC	25,987	$0.15M	0.0%	N/A	0.045%
2/17/2025	BVF Inc. IL	5,715,893	$33.32M	1.1%	-37.4%	9.975%
2/17/2025	Balyasny Asset Management L.P.	1,127,589	$6.57M	0.0%	+59.0%	1.968%
2/17/2025	Bank of America Corp DE	865,339	$5.05M	0.0%	+110.6%	1.510%
2/17/2025	BNP Paribas Financial Markets	193,748	$1.13M	0.0%	N/A	0.338%
2/17/2025	Ameriprise Financial Inc.	449,698	$2.62M	0.0%	-2.9%	0.785%
2/14/2025	Boxer Capital Management LLC	650,000	$3.79M	0.3%	N/A	1.134%
2/14/2025	Jane Street Group LLC	43,737	$0.26M	0.0%	-44.7%	0.076%
2/14/2025	Schonfeld Strategic Advisors LLC	505,400	$2.95M	0.0%	+9.4%	0.882%
2/14/2025	Northern Trust Corp	423,787	$2.47M	0.0%	+8.7%	0.740%
2/14/2025	Aquatic Capital Management LLC	31,565	$0.18M	0.0%	N/A	0.055%
2/14/2025	Boothbay Fund Management LLC	31,226	$0.18M	0.0%	+10.8%	0.054%
2/14/2025	Susquehanna Fundamental Investments LLC	10,976	$64K	0.0%	N/A	0.019%
2/14/2025	Virtus ETF Advisers LLC	10,579	$62K	0.0%	+43.1%	0.018%
2/14/2025	Voya Investment Management LLC	12,523	$73K	0.0%	-76.0%	0.022%
2/14/2025	Adage Capital Partners GP L.L.C.	365,198	$2.13M	0.0%	-8.7%	0.637%
2/14/2025	Syon Capital LLC	13,151	$77K	0.0%	N/A	0.023%
2/14/2025	Price T Rowe Associates Inc. MD	26,112	$0.15M	0.0%	-17.0%	0.046%
2/14/2025	Silverarc Capital Management LLC	233,281	$1.36M	0.3%	-48.7%	0.407%
2/14/2025	Hsbc Holdings PLC	10,005	$58K	0.0%	N/A	0.017%
2/14/2025	Avoro Capital Advisors LLC	1,651,982	$9.63M	0.1%	N/A	2.883%
2/14/2025	Bain Capital Life Sciences Investors LLC	7,470,214	$43.55M	5.1%	N/A	13.037%
2/14/2025	Tower Research Capital LLC TRC	22,714	$0.13M	0.0%	+1,436.8%	0.040%
2/14/2025	Dimensional Fund Advisors LP	1,332,792	$7.77M	0.0%	-3.2%	2.326%
2/13/2025	Marshall Wace LLP	192,943	$1.13M	0.0%	-19.7%	0.337%
2/13/2025	Walleye Capital LLC	67,007	$0.39M	0.0%	N/A	0.117%
2/13/2025	XTX Topco Ltd	48,032	$0.28M	0.0%	+89.6%	0.084%
2/13/2025	Barclays PLC	114,879	$0.67M	0.0%	+21.0%	0.200%
2/13/2025	Renaissance Technologies LLC	157,300	$0.92M	0.0%	+435.0%	0.275%
2/13/2025	Legal & General Group Plc	29,716	$0.17M	0.0%	-8.5%	0.052%
2/13/2025	Aristides Capital LLC	32,500	$0.19M	0.0%	N/A	0.057%
2/13/2025	Wells Fargo & Company MN	22,725	$0.13M	0.0%	+35.5%	0.040%
2/12/2025	ExodusPoint Capital Management LP	91,298	$0.53M	0.0%	+30.7%	0.159%
2/12/2025	Geode Capital Management LLC	926,162	$5.40M	0.0%	-0.9%	1.616%
2/12/2025	Franklin Resources Inc.	273,706	$1.60M	0.0%	+1,714.9%	0.478%
2/12/2025	Alliancebernstein L.P.	313,982	$1.83M	0.0%	+77.7%	0.548%
2/12/2025	Wellington Management Group LLP	1,525,484	$8.84M	0.0%	+52.1%	2.662%
2/12/2025	Schroder Investment Management Group	533,111	$2.99M	0.0%	+548.7%	0.930%
2/12/2025	Pictet Asset Management Holding SA	1,883,354	$10.98M	0.0%	+12.9%	3.287%
2/12/2025	JPMorgan Chase & Co.	160,751	$0.94M	0.0%	-11.2%	0.281%
2/11/2025	Pier Capital LLC	272,372	$1.59M	0.2%	N/A	0.475%
2/11/2025	EntryPoint Capital LLC	69,526	$0.41M	0.2%	+101.3%	0.121%
2/11/2025	Vanguard Group Inc.	2,685,009	$15.65M	0.0%	+6.0%	4.686%
2/11/2025	Fox Run Management L.L.C.	13,769	$80K	0.0%	N/A	0.024%
2/11/2025	KLP Kapitalforvaltning AS	5,100	$30K	0.0%	N/A	0.009%
2/11/2025	American Century Companies Inc.	11,738	$68K	0.0%	-59.6%	0.020%
2/11/2025	Teacher Retirement System of Texas	10,352	$60K	0.0%	N/A	0.018%
2/10/2025	Monaco Asset Management SAM	25,000	$0.15M	0.0%	N/A	0.044%
2/7/2025	HighTower Advisors LLC	87,476	$0.51M	0.0%	N/A	0.153%
2/7/2025	AlphaQuest LLC	18,414	$0.11M	0.0%	+867.6%	0.032%
2/7/2025	Candriam S.C.A.	1,551,562	$9.05M	0.1%	+3.0%	2.708%
2/6/2025	Dana Investment Advisors Inc.	92,039	$0.54M	0.0%	+7.3%	0.161%
2/6/2025	Victory Capital Management Inc.	93,100	$0.54M	0.0%	-89.1%	0.162%
2/6/2025	Charles Schwab Investment Management Inc.	332,950	$1.94M	0.0%	+0.7%	0.581%
2/4/2025	Bank of New York Mellon Corp	128,666	$0.75M	0.0%	-2.7%	0.225%
2/4/2025	Y Intercept Hong Kong Ltd	19,001	$0.11M	0.0%	N/A	0.033%
1/30/2025	Vontobel Holding Ltd.	10,647	$62K	0.0%	N/A	0.019%
1/17/2025	SG Americas Securities LLC	17,475	$0.10M	0.0%	+33.8%	0.030%
1/15/2025	Hennion & Walsh Asset Management Inc.	212,246	$1.24M	0.1%	+80.5%	0.370%
12/26/2024	JPMorgan Chase & Co.	181,032	$2.16M	0.0%	+658.7%	0.316%
11/19/2024	Barclays PLC	94,915	$1.13M	0.0%	+105.0%	0.166%
11/16/2024	Geode Capital Management LLC	934,929	$11.17M	0.0%	-11.8%	1.632%
11/15/2024	Conway Capital Management Inc.	10,000	$0.12M	0.1%	N/A	0.017%
11/15/2024	Barclays PLC	94,915	$1.13M	0.0%	+105.0%	0.166%
11/15/2024	XTX Topco Ltd	25,332	$0.30M	0.0%	+103.4%	0.044%
11/15/2024	EP Wealth Advisors LLC	48,655	$0.58M	0.0%	+5.2%	0.085%
11/15/2024	Wellington Management Group LLP	1,002,685	$11.97M	0.0%	+10.8%	1.750%
11/15/2024	State Street Corp	1,969,963	$23.52M	0.0%	+1.1%	3.438%
11/15/2024	Point72 Asset Management L.P.	3,687,374	$44.03M	0.1%	+14.8%	6.435%
11/15/2024	Ikarian Capital LLC	92,000	$1.10M	0.1%	N/A	0.161%
11/15/2024	Jacobs Levy Equity Management Inc.	74,919	$0.90M	0.0%	-14.3%	0.131%
11/15/2024	Janus Henderson Group PLC	17,800	$0.21M	0.0%	-68.2%	0.031%
11/15/2024	HighVista Strategies LLC	212,185	$2.53M	0.9%	-14.4%	0.370%
11/14/2024	Portland Investment Counsel Inc.	12,000	$0.14M	0.1%	N/A	0.021%
11/14/2024	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	75,974	$0.91M	0.0%	-9.1%	0.133%
11/13/2024	Great Point Partners LLC	1,000,000	$11.94M	3.5%	+25.5%	1.746%
11/13/2024	Dynamic Technology Lab Private Ltd	19,894	$0.24M	0.0%	N/A	0.035%
11/12/2024	Pitcairn Co.	24,546	$0.29M	0.0%	-9.1%	0.043%
11/12/2024	Charles Schwab Investment Management Inc.	330,761	$3.95M	0.0%	+168.5%	0.578%
11/9/2024	Intech Investment Management LLC	13,686	$0.16M	0.0%	N/A	0.024%
11/5/2024	Victory Capital Management Inc.	851,512	$10.17M	0.0%	+9.9%	1.487%

Data available starting January 2016

See Full Table

Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 3 clinical trial for the treatment of recurrent, locally advanced, or metastatic estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer; and OP-1250 combine with CDK4/6 inhibitors palbociclib, ribociclib, and alpelisib in Phase 1/2 clinical trial for the treatment of recurrent, locally advanced, or metastatic estrogen receptor-positive human epidermal growth factor receptor 2-negative breast cancer, as well as develops OPERA-01 for the of ER+/HER2- advanced or metastatic breast cancer. The company was formerly known as CombiThera, Inc. and changed its name to Olema Pharmaceuticals, Inc. in March 2009. Olema Pharmaceuticals, Inc. was incorporated in 2006 and is headquartered in San Francisco, California.

Today's Range

Now: $4.41

$4.39

$4.60

50 Day Range

MA: $5.22

$4.20

$6.63

52 Week Range

Now: $4.41

$3.95

$16.62

Volume

607,701 shs

Average Volume

826,265 shs

Market Capitalization

$252.68 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.11

Who are the company insiders with the largest holdings of Olema Pharmaceuticals?: Olema Pharmaceuticals' top insider investors include:
Bain Capital Life Sciences Inv (Major Shareholder)
Biocapital Advisors L Paradigm (Major Shareholder)
Bvf Partners L P/Il (Director)
G Walmsley Graham (Director)
Cyrus Harmon (Director)
David C Myles (Insider)
Sean Bohen (CEO)
Naseem Zojwalla (Insider)
Learn More about top insider investors at Olema Pharmaceuticals.
Who are the major institutional investors of Olema Pharmaceuticals?: Olema Pharmaceuticals' top institutional shareholders include:
Bain Capital Life Sciences Investors LLC — 13.04%
Paradigm Biocapital Advisors LP — 12.75%
BVF Inc. IL — 9.98%
Point72 Asset Management L.P. — 6.41%
Deep Track Capital LP — 6.01%
MPM Bioimpact LLC — 5.08%
Learn More about top institutional investors of Olema Pharmaceuticals stock.
Which major investors are selling Olema Pharmaceuticals stock?: During the previous quarter, OLMA stock was sold by these institutional investors:
BVF Inc. IL
Victory Capital Management Inc.
Deep Track Capital LP
Silverarc Capital Management LLC
Marshall Wace LLP
Dimensional Fund Advisors LP
Voya Investment Management LLC
Jane Street Group LLC
Within the last year, company insiders that have sold Olema Pharmaceuticals company stock include:
Bain Capital Life Sciences Inv (Major Shareholder)
Biocapital Advisors L Paradigm (Major Shareholder)
Bvf Partners L P/Il (Director)
G Walmsley Graham (Director)
Cyrus Harmon (Director)
Learn More investors selling Olema Pharmaceuticals stock.
Which major investors are buying Olema Pharmaceuticals stock?: In the previous quarter, OLMA stock was acquired by institutional investors including:
Bain Capital Life Sciences Investors LLC
Lightspeed Management Company L.L.C.
Paradigm Biocapital Advisors LP
Avoro Capital Advisors LLC
Millennium Management LLC
Boxer Capital Management LLC
Wellington Management Group LLP
Bank of America Corp DE
Within the previous year, these company insiders have bought Olema Pharmaceuticals stock:
Bain Capital Life Sciences Inv (Major Shareholder)
Biocapital Advisors L Paradigm (Major Shareholder)
Bvf Partners L P/Il (Director)
G Walmsley Graham (Director)
Learn More investors buying Olema Pharmaceuticals stock.